Randomised controlled trial of effect on quality of life of prescription of second generation (atypical) versus first generation antipsychotic drugs in schizophrenia [Abstract]

P. B. Jones, L Davies, TR Barnes, R. M. Murray, G Dunn, K P Hayhurst, A Markwick, H Lloyd, S W Lewis

Division of Psychology & Mental Health (L5)

Research output: Contribution to journal › Meeting Abstract

1 Article

1 results

2006
Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment
Lewis, S. W., Davies, L., Jones, P. B., Barnes, T. R. E., Murray, R. M., Kerwin, R., Taylor, D., Hayhurst, K., Markwick, A., Lloyd, H. & Dunn, G., May 2006, In: Health Technology Assessment. 10, 17, p. 1-165 165 p.
Research output: Contribution to journal › Article › peer-review

Open Access